Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Loveday

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Lancet (London, England)|March 21, 1987
Prevalence of antibodies to human immunodeficiency virus, gonorrhoea rates, and changed sexual behaviour in homosexual men in LondonC A Carne, I V Weller, A M Johnson, et al.
Journal of Clinical Microbiology|May 23, 1998
Comparison of culture- and non-culture-based methods for quantification of viral load and resistance to antiretroviral drugs in patients given zidovudine monotherapyR S Tedder, S Kaye, C Loveday, et al.
Journal of Clinical Microbiology|December 1, 1996
Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasmaR Schuurman, D Descamps, G J Weverling, et al.
Immunology Letters|April 15, 1999
'Naïve' and 'memory' CD4+ T-cells and T-cell receptor (TCR) V beta repertoire dynamics are independent of the levels of viremia following HIV seroconversionD J King, P Amjadi, R Tilling, et al.
JAMA|July 10, 1996
Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working GroupS Staszewski, C Loveday, J J Picazo, et al.
AIDS (London, England)|February 24, 2001
Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centreA Mocroft, M Youle, A Moore, et al.
AIDS (London, England)|August 10, 2000
Interventions to prevent vertical transmission of HIV-1: effect on viral detection rate in early infant samplesD T Dunn, R J Simonds, M Bulterys, et al.
AIDS (London, England)|April 20, 1999
In vivo HIV-1 replicative capacity in early and advanced infectionA N Phillips, A R McLean, C Loveday, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1996
Safety, tolerance, and efficacy of atevirdine in asymptomatic human immunodeficiency virus-infected individualsA M Been-Tiktak, I Williams, H M Vrehen, et al.
Lancet (London, England)|November 5, 1997
HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial. The National Virology Groups. Delta Virology Working Group and Coordinating CommitteeF Brun-Vézinet, C Boucher, C Loveday, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Lancet (London, England)|March 21, 1987
Prevalence of antibodies to human immunodeficiency virus, gonorrhoea rates, and changed sexual behaviour in homosexual men in LondonC A Carne, I V Weller, A M Johnson, et al.
Journal of Clinical Microbiology|May 23, 1998
Comparison of culture- and non-culture-based methods for quantification of viral load and resistance to antiretroviral drugs in patients given zidovudine monotherapyR S Tedder, S Kaye, C Loveday, et al.
Journal of Clinical Microbiology|December 1, 1996
Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasmaR Schuurman, D Descamps, G J Weverling, et al.
Immunology Letters|April 15, 1999
'Naïve' and 'memory' CD4+ T-cells and T-cell receptor (TCR) V beta repertoire dynamics are independent of the levels of viremia following HIV seroconversionD J King, P Amjadi, R Tilling, et al.
JAMA|July 10, 1996
Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working GroupS Staszewski, C Loveday, J J Picazo, et al.
AIDS (London, England)|February 24, 2001
Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centreA Mocroft, M Youle, A Moore, et al.
AIDS (London, England)|August 10, 2000
Interventions to prevent vertical transmission of HIV-1: effect on viral detection rate in early infant samplesD T Dunn, R J Simonds, M Bulterys, et al.
AIDS (London, England)|April 20, 1999
In vivo HIV-1 replicative capacity in early and advanced infectionA N Phillips, A R McLean, C Loveday, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1996
Safety, tolerance, and efficacy of atevirdine in asymptomatic human immunodeficiency virus-infected individualsA M Been-Tiktak, I Williams, H M Vrehen, et al.
Lancet (London, England)|November 5, 1997
HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial. The National Virology Groups. Delta Virology Working Group and Coordinating CommitteeF Brun-Vézinet, C Boucher, C Loveday, et al.
Pageof 11